MAPT and Alzheimer disease: The gut microbiome is now recognized as playing a critical role in neurodegeneration and AD progression, doing so by affecting Aβ oligomers and plaques, tau aggregates, and neuroinflammation; manipulation of the gut microbiome with antibiotics has resulted in both a reduced progression of AD and a reduction in Aβ deposition [53].